InvestorsHub Logo
icon url

dia76ca

12/16/22 9:08 PM

#392951 RE: peeved #392945

You are correct. $35 is better than $8.6.
However $350 is better than $35.
And I do expect a partnership leading up to a buyout.
A partnership alone could bring the share price closer to $100.
Approvals in Australia, UK, Europe and Canada...and the US could triple that.
The safest and most effective prevention and /or treatment for treatment for ALzheimers, PDD, Retts, Fragile X, Autism etc. could easily produce revenues over $20 billion a year. Final share price? 4 digits is entirely possible IMO!
icon url

bas2020

12/16/22 11:46 PM

#392976 RE: peeved #392945

LOL
icon url

jav0033

12/17/22 1:46 AM

#392980 RE: peeved #392945

BIVI coming strong and might steal AVXL’s thunder due to slow pace and mismanagements
icon url

JWC3

12/17/22 3:00 AM

#392981 RE: peeved #392945

Extremely unlikely that ANAVEX will be required another p3! Maybe there will be P4 ? Conditional approval could be. However A 2-73 will be in the marketplace soon!